SavedAdd your journal

Journals / Türkiye Çocuk Hastalıkları Dergisi / 2011 / Cilt: 5 - Sayı: 3

METHEMOGLOBINEMIA DUE TO PRILOCAINE WHICH TREATED

Oral Metilen Mavisi İle Tedavi Edilen, Prilokaine Bağlı Bir Methemoglobinemi Olgusu

İbrahim CANER
Ayhan TAŞTEKİN
Özlem ZİRAATÇİ
Pages
172–176
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we report an infant who developed methemoglobinemia after prilocaine injection for local anesthesia and treated successfully with oral methylene blue

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prilocaine is a strong local anesthetic, widely used in children and adults in cream or injectable form.
📊
Key Findings & Data:In the literature, there have been many case reports presenting patients developing acquired methemoglobinemia during its usage in therapeutic doses.
💡
Conclusion & Impact:In this paper, we report an infant who developed methemoglobinemia after prilocaine injection for local anesthesia and treated successfully with oral methylene blue
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Prilokain · methemoglobinemi · metilen mavisi

Abstract

Prilocaine is a strong local anesthetic, widely used in children and adults in cream or injectable form. In the literature, there have been many case reports presenting patients developing acquired methemoglobinemia during its usage in therapeutic doses. In this paper, we report an infant who developed methemoglobinemia after prilocaine injection for local anesthesia and treated successfully with oral methylene blue

Özet

Prilokain, krem veya enjektabl form şeklinde çocuklarda ve erişkinlerde yaygın olarak kullanılan güçlü bir lokal anesteziktir. Literatürde normal dozda prilokainin uygulaması sonrası yan etki olarak oluşan methemoglobinemi ile ilgili çok sayıda vaka sunulmuştur. Tedavide metilen mavisi başarıyla kullanılmaktadır. Bu yazıda lokal anestezi amacıyla prilokain kullanımına bağlı methemoglobinemi gelişen ve oral metilen mavisi ile tedavi edilen bir olgu sunulmuştur.

🔖

Cite This Article

CANER, İ., TAŞTEKİN, A., ZİRAATÇİ, Ö. (2022). METHEMOGLOBINEMIA DUE TO PRILOCAINE WHICH TREATED. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 5 - Sayı: 3, 172–176. https://ajindex.com/articles/627635

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Quirolo K, Vichinsky E. Hemoglobin Disorder. In: Behr- man RE, Kleigman RM Jensen HB (eds), Nelson Textbook of Pediatrics. Philadelpiha: Saunders 2004;1623-1634.
  2. Kreutz RW, Kinni ME. Life-threatining toxic methemog- lobinemia induced by prilocaine. Oral Surg Oral Med Oral Pathol 1983;56(5):480-2.
  3. Bristol I, Brown J, Slomovitz BM, Shannon VR, Eifel PJ. Methemoglobinemia induced by topical vaginal sulfanila- mide cream in a patient with cervical cancer: a case report. Gynecol Oncol 2005;97(3):953-6.
  4. Armstrong C, Burak KW, Beck PL. Benzocaine-induced methemoglobinemia: a condition of which all endoscopists should be aware. Can J Gastroenterol 2004;18(10):625-9.
  5. Bayard M, Farrow J, Tudiver F. Acute methemoglobinemia after endoscopy. J Am Board Fam Pract 2004;17(3):227-9.
  6. Benini D, Vivo L, Fanos V. Acquired methemoglobinemia: a case report. Pediatr Med Chir. 1998;20(6):411-3.
  7. Kara A, Yigit S, Aygün C, Oran O. Toxic methemoglobine- mia after injection of prilocaine in a newborn. Turk J Pedi- atr 1998;40(4):589-92. Kayaalp O. Lokal Anestezikler: Rasyonel Tedavi Yönün- den Tıbbi Farmakoloji: Hacettepe-Taş 8. Basım, 1998:797- 810. Lunenfeld E, Kane GC. Methemoglobinemia: sudden dyspnea and oxyhemoglobin desaturation after esophago- duodenoscopy. Respir Care 2004;49(8):940-2.
  8. Taddio A, Stevens B, Craig K, Rastogi P, Ben-David S, Shennan A, et al. Efficacy and safety of lidokaine-prilokai- ne cream for pain during circumcision. N Engl J Med 1997; 336(18):1197-201.
  9. Kumar AR, Dunn N, Naqvi M. Methemoglobinemia as- sociated with a prilocaine-lidokaine cream. Clin Pediatr 1997;36(4):239-40.
  10. Sinisterra S, Miravet E, Alfonso I, Soliz A, Papazian O. Methemoglobinemia in an infant receiving nitric oxide af- ter the use of eutectic mixture of local anesthetic. J Pediatr 2002;141(2):285-6.
  11. Hahn IH, Hoffman RS, Nelson LS. EMLA-induced met- hemoglobinemia and systemic topical anesthetic toxicity. J Emerg Med 2004;26(1):85-8.
  12. Aydoğan M, Gedikbaşı Toprak D, Türker G, Zengin E, Arı- soy ES, Gökalp AS. Prilokaine bağlı toksik methemoglo- binemide intravenöz askorbik kullanımı: İki vaka takdimi. Çocuk sağlığı ve Hastalıkları Dergisi 2005;48(1):65-8. Gunter JB. Benefit and risks of local anesthetics in infants and children. Pediatr Drugs 2002;4(10):649-72.
  13. Gourrier E, Karoubi P, el Hanache A, Merbouche S, Mo- uchnino G, Dhabhi S, et al. Use of EMLA cream in pre- matüre and full-term newborn infants. Arch Pediatr 1995;2(11):1041-6.
  14. Brisman M, Ljung BM, Otterbom I, Larsson LE, Adreas- s